CAPTRUST Financial Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Sell |
|
|||||
|
2025
Q1 | $1.72M | Sell |
|
|||||
|
2024
Q4 | $1.51M | Buy |
|
|||||
|
2024
Q3 | $1.33M | Buy |
|
|||||
|
2024
Q2 | $874K | Sell |
|
|||||
|
2024
Q1 | $544K | Sell |
|
|||||
|
2023
Q4 | $883K | Buy |
|
|||||
|
2023
Q3 | $742K | Sell |
|
|||||
|
2023
Q2 | $935K | Buy |
|
|||||
|
2023
Q1 | $438K | Buy |
|
|||||
|
2022
Q4 | $384K | Buy |
|
|||||
|
2022
Q3 | $295K | Buy |
|
|||||
|
2022
Q2 | $187K | Buy |
|
|||||
|
2022
Q1 | $201K | Buy |
|
|||||
|
2021
Q4 | $153K | Buy |
|
|||||
|
2021
Q3 | $161K | Buy |
|
|||||
|
2021
Q2 | $119K | Buy |
|
|||||
|
2021
Q1 | $94K | Buy |
|
|||||
|
2020
Q4 | $21K | Sell |
|
|||||
|
2020
Q3 | $32K | Hold |
|
|||||
|
2020
Q2 | $33K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $71K | Buy |
|
|||||
|
2019
Q2 | $11K | Hold |
|
|||||
|
2019
Q1 | $14K | Hold |
|
|||||
|
2018
Q4 | $11K | Hold |
|
|||||
|
2018
Q3 | $13K | Hold |
|
|||||
|
2018
Q2 | $15K | Hold |
|
|||||
|
2018
Q1 | $15K | Hold |
|
|||||
|
2017
Q4 | $19K | Hold |
|
|||||
|
2017
Q3 | $18K | Buy |
|